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Abstract
Background: Semiconductor quantum dots (QDs) hold increasing potential for cellular imaging
both in vitro and in vivo. In this report, we aimed to evaluate in vivo multiplex imaging of mouse
embryonic stem (ES) cells labeled with Qtracker delivered quantum dots (QDs).
Results: Murine embryonic stem (ES) cells were labeled with six different QDs using Qtracker. ES
cell viability, proliferation, and differentiation were not adversely affected by QDs compared with
non-labeled control cells (P = NS). Afterward, labeled ES cells were injected subcutaneously onto
the backs of athymic nude mice. These labeled ES cells could be imaged with good contrast with
one single excitation wavelength. With the same excitation wavelength, the signal intensity, defined
as (total signal-background)/exposure time in millisecond was 11 ± 2 for cells labeled with QD 525,
12 ± 9 for QD 565, 176 ± 81 for QD 605, 176 ± 136 for QD 655, 167 ± 104 for QD 705, and
1,713 ± 482 for QD 800. Finally, we have shown that QD 800 offers greater fluorescent intensity
than the other QDs tested.
Conclusion: In summary, this is the first demonstration of in vivo multiplex imaging of mouse ES
cells labeled QDs. Upon further improvements, QDs will have a greater potential for tracking stem
cells within deep tissues. These results provide a promising tool for imaging stem cell therapy non-
invasively in vivo.
Background
Quantum dots (QDs) are emerging as an exciting new
class of fluorescent probes for non-invasive in vivo imag-
ing [1-5]. Compared to conventional organic dyes, QDs
offer a number of fascinating optical and electronic prop-
erties. QDs are semiconductor nanocrystals that can be
excited by a wide range of light, ranging from ultraviolet
to near-infrared, and can emit different wavelengths of
light, depending on their size and composition. QDs have
broad excitation spectra and narrow emission spectra
(Figure 1). Because QDs can be excited by one single
wavelength and can emit light of different wavelengths,
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they are ideal probes for multiplex imaging [6]. By con-
trast, conventional organic dyes cannot be easily synthe-
sized to emit different colors and have narrow excitation
spectra and broad emission spectra that often cross into
the red wavelengths, making it difficult to use these dyes
for multiplexing. In addition, QDs have exceptional pho-
tostability (reviewed by Medintz et al. [7]). Due to their
extreme brightness and resistance to photobleaching [8],
QDs are ideal for live cell imaging wherein cells must be
kept under the excitation light source for long periods of
time. Their intense brightness is also helpful for single
particle detection (reviewed by Michalet et al. [9]). By
comparison, conventional dyes often photobleach, mak-
ing longitudinal tracking difficult.
QDs' photophysical properties have broadened their
application and shown great promise as imaging probes
in bioimaging, drug discovery, and diagnosis. To keep up
with their burgeoning utility, current QD technology has
rapidly evolved. QDs have been used for tumor targeting
and imaging [1], lymph node [3] and vascular mapping
[5], and cellular trafficking [8,10]. QDs can be delivered in
a targeted fashion by conjugating them with ligands and
antibodies. QDs can also be introduced into cells non-
specifically, which serves as a potential tracking marker
for cellular imaging.
Stem cell therapy holds promise for treatment of intracta-
ble conditions such as Parkinson's disease, ischemic heart
disease, diabetes, and degenerative joint diseases [11-14].
There are two types of cells used in stem cell therapy, adult
stem cells and embryonic stem (ES) cells. Of the two, ES
cells are the ultimate source for use in cell-based therapy
because they posses a virtually unlimited capacity for self-
renewal and pluripotency, which is defined as the ability
to differentiate into all cell types, including neurons, car-
diomyocytes, hepatocytes, islet cells, skeletal muscle cells,
and endothelial cells [15]. In stem cell therapy, monitor-
ing of cell survival and location after transplantation is
important for determining their efficacy. Because the
absorption and scattering of light in biological tissue can
be considerable, any optical signal transmitted from deep
Emission and excitation spectra of QDs (provided by Quamtum Corp.) and Maestro optical system Figure 1
Emission and excitation spectra of QDs (provided by Quamtum Corp.) and Maestro optical system. (A) Excita-
tion and (B) emission spectra of QDs used in the labeling experiments. Dark green = QD 525; green = QD 565; yellow = QD 
585; orange = QD 605; red = QD 655; brown = QD 705; blue = QD 800. (C) The Maestro Optical imaging system.
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tissues to the surface tends to diminish in strength
(reviewed by Choy et al. [16]). With QDs' many advan-
tages over traditional organic dyes, QDs may provide an
excellent tool for imaging stem cell therapy.
In this study, we use the peptide-based reagent QTracker
to label mouse ES cells with QDs and evaluate the utility
of QDs for imaging stem cell therapy. We next show that
labeling mouse ES cells with QDs does not adversely affect
ES cell viability, proliferation, and differentiation. Finally,
we examine QDs' potential for imaging ES cells in vitro
and in vivo.
Results
Qtracker intracellular QD delivery
To deliver QDs, we used peptide-based QTracker, which
has been shown to be an excellent and easy tool for study
live cell mobility [17] and cell fusion [18]. In order to
determine transfection efficiency in ES cells, labeled ES
cells were analyzed by flow cytometry. Figure 2a shows a
representative histogram plot based on forward scatter
and side scatter gated cells. The red line shows fluores-
cence intensity of control unlabeled cells and the green
line represents the labeled cells. As more QDs were taken
up by these cells, the fluorescence intensity increased.
Around 72% of the cells were positive 24 hours after labe-
ling and the mean fluorescence intensity (MFI) was 521.
However, by day 4 the percentage of positive cells had
dropped to ~4% and by day 7 only ~0.7% of the cells were
positive by FACS analysis when compared to control unla-
beled cells. Fluorescence microscopy (Carl Zeiss Axiovert
200M) was used to image the cells on day 1. Representa-
tive brightfield and fluorescent images are shown in Fig-
ure 2b. ES cells can be labeled and monitored by FACS
analysis up to 7 days.
QDs do not affect ES cell viability and proliferation
Toxicity of QDs is a key factor in determining whether it
will be a feasible probe for both cellular and clinical use.
We carefully examined QDs' effect on ES cells by Trypan
Qtracker intracellular QD delivery quantified by flow cytometry Figure 2
Qtracker intracellular QD delivery quantified by flow cytometry. (A) Flow cytometry detection of QD labeling of 
mouse ES cells on day 1, day 4, and day 7. Red line = unlabeled cells as control; green line = cells labeled with QD. (B) Fluores-
cent images of cells labeled with QDs on day 1 post labeling.
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blue exclusion assay and a CyQuant proliferation assay.
Figure 3a shows the percentage of live cells in triplicates at
24, 48 and 72 hours post QD labeling. Overall, there was
no significant difference between labeled and unlabeled
ES cells (P = NS) for all QDs that were tested: QD 525,
565, 605, 655, 705, and 800. To evaluate cell prolifera-
tion, we used the CyQuant assay, which measures the
amount of nucleic acids in each well, thereby giving an
accurate count of the number of cells in the experimental
condition. As shown in Figure 3b, there was also no signif-
icant difference between QD labeled ES cells and unla-
beled ES cells (P = NS).
QDs have no profound effects on ES cell differentiation in 
vitro
Having demonstrated that QD labeling had no detectable
effect on ES cell growth, we next tested its effect on cellular
development and differentiation. Dubertret et al. showed
that at high concentrations, QDs injected into an individ-
ual blastomere of Xenopus during very early cleavage
stages can cause apparent abnormalities in late stage
embryos [4]. Therefore, we examined the pluripotency of
QD labeled mouse ES cells to ascertain if any develop-
mental interference would occur. In the literature, both
human and murine ES cells have well-documented differ-
entiation and replication capacities [19,20]. Mouse ES
cells were differentiated in vitro by hanging drop assay. We
Effects of QDs on ES cell viability, proliferation, and differentiation Figure 3
Effects of QDs on ES cell viability, proliferation, and differentiation. (A) Trypan blue exclusion assay and (B) CyQuant 
cell proliferation assay both showed no significant difference between unlabeled ES cells and labeled ES cell at 24, 48, and 72 
hours. (C) RT-PCR analysis showed the levels of endoderm (AFP), mesoderm (Flk-1), and ectoderm (Ncam) germ layer 
marker increased from day 0 to day 14 of spontaneous ES cell differentiation using the hanging drop assay. The stem cell 
marker Oct4 decreased during the same period as expected. GAPDH is a loading control for all cells. Both QD labeled and 
unlabeled ES cells showed similar pattern on RT-PCR analysis.
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then isolated RNA samples from undifferentiated mouse
ES cells and embryoid body at day 14 and analyzed them
by RT-PCR. Both labeled and unlabeled undifferentiated
ES cells (day 0) expressed ES cell specific marker Oct4.
Likewise, both labeled and unlabeled differentiated ES
cells (day 14) expressed specific markers for endoderm
(alpha-1-fetoprotein, AFP), mesoderm (fetal liver kinase-
1, Flk1), and ectoderm (neural cell adhesion molecule,
Ncam) germ layers [21] (Figure 3c).
In vivo multiplex imaging using QDs
One of the most attractive qualities of QDs is their capa-
bility for multiplex imaging (i.e., tracking different cell
populations with different QDs using different emission
wavelengths at the same time). In addition, as QDs are
larger than organic dyes, they are not transferred between
cells until the cells fuse. Therefore, QDs can provide an
excellent tool for studying cell-cell interactions [18]. Here
we used QD 525, 565, 605, 655, 705, and 800 to label 1
× 106 ES cells as described. Right after QD labeling, the
labeled cells were subcutaneously injected into various
locations on the back of athymic nude mice. Images were
taken right after injection and the resulting stacked image
shown in Figure 4a. The fluorescent intensity was directly
proportional to the product of extinction coefficient and
the quantum yield. Even though the QDs were excited by
the same wavelength, the energy absorbed was different
for each QD, causing some QDs to absorb less energy than
others. This observation is due to the QDs' ability to pro-
duce different light levels at the same excitation wave-
length as shown in Figure 1a. Therefore, QDs with longer
emission wavelengths will appear brighter. With the same
excitation wavelength, the signal intensity (defined as:
(total signal-background)/exposure time in millisecond)
was 11 ± 2 for cells labeled with QD 525, 12 ± 9 for QD
565, 176 ± 81 for QD 605, 176 ± 136 for QD 655, 167 ±
104 for QD 705, and 1,713 ± 482 for QD 800. Quantifi-
cation of these results is shown in Figure 4b. In order to
evaluate which QD was better for non-invasive imaging,
we imaged the same transplanted mice longitudinally.
After day 2, ES cells labeled with QD 525, 565, 605, 655,
and 705 could not be detected in vivo using the Maestro
system. In contrast, QD 800 signal could be detected up to
14 days in animals post injection, which is likely due to its
higher extinction coefficient and wider emission spectra
within near-infrared region.
Detection sensitivity for in vivo imaging using QD800
We have shown that QD 800 offers greater fluorescent
intensity than the other QDs tested. However, its detec-
tion sensitivity is currently unknown. In particular, what
are the fewest number of labeled cells that can be detected
by the Maestro system and for what duration? In order to
determine the detection sensitivity for in vivo imaging, we
Multiplex imaging capability of QD in live animals Figure 4
Multiplex imaging capability of QD in live animals. (A) 1 × 106 ES cells labeled with QD 525, 565, 605, 655, 705, and 800 
were subcutaneously injected on the back of the athymic nude mice right after labeling and the image was taken with a single 
excitation light source right after injection. The quantification of fluorescent signal intensity defined as total signal-background/
exposure time in millisecond was shown in (B).
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subcutaneously injected different numbers of QD 800
labeled ES cells (1 × 104, 1 × 105, and 1 × 106) into the
back of the mice right after labeling. Images were taken 1
hour post injection and then daily thereafter for 2 weeks
using the Maestro Optical imaging system (excitation: 465
nm, emission: 515 long-pass). Figure 5a showed that ~1 ×
105 subcutaneously injected QD labeled cells could be
seen through the Maestro system. The signal intensity
quantification is shown in Figure 5b. Since QD 800 could
also be excited by red light, which offered better tissue
penetration, we also imaged the mice using excitation fil-
ter 640 nm and emission filter 700 long-pass (Figure 5c).
We compared the resulting image to that obtained from
earlier settings. Although we still could not visualize the 1
× 104 labeled cells, the signal intensity from 1 × 106
labeled cells did increase with the red light excitation
(from 1538 ± 793 to 2378 ± 352) (Figure 5d). Again, sig-
nals were still present in the animals up to day 14 using
excitation filter 640 nm as shown in Figure 5e.
Postmortem histologic analysis of QD labeled ES cells
After imaging, animals were sacrificed and the subcutane-
ous tumor developed from 1 × 106 QD800 labeled ES cells
was removed for detailed postmortem analysis at day 28
post-injection. Conventional histology using H&E stains
confirmed the intact in vivo differentiation ability of QD
labeled ES cells in living animals (Figure 6). These in vivo
histologic data are concordant with previous in vitro RT-
PCR data shown in Figure 4, which further suggest that
QDs do not affect the developmental pluripotency of ES
cells. However, we could not observe any QDs under
microscopic level at day 28, likely due to dilution and dif-
fusion effects.
Discussion
Stem cells offer an exciting new branch of therapy to treat
a variety of conditions and diseases. It is therefore impor-
tant to develop methods to monitor cell survival and loca-
tion after transplantation. Due to its many advantages
over conventional organic dyes, QDs serve as good candi-
dates to monitor these parameters. In order to evaluate
their in vivo ability, we delivered them by using commer-
cially available QTracker. Strategies for ex vivo cell labeling
by QDs include non-specific endocytosis, microinjection,
liposome mediated uptake, electroporation, and peptide-
based reagents. Previous studies have shown that the lipo-
some-based reagent Lipofectamin 2000 had the highest
delivery efficiency, but the QDs were delivered in aggre-
gates [22]. Electroporation also delivered QDs in aggre-
gates [22], and may even cause cell death. Peptide-based
QTracker [23] reagents (Invitrogen, CA) deliver QDs into
the live cells, and have been shown to be an excellent and
easy tool for studying live cell mobility [17] and cell
fusion [18].
In this report, we evaluated ES cells labeled with QDs
using commercially available Qtracker for non invasive in
vivo imaging in living mice. Twenty-four hours after labe-
ling ES cells with QDs, 72% of the cells were positive.
However, by day 4 the percentage of positive cells
dropped to 4%. This dramatic decrease could be due to
the rapid division of ES cells (doubling time of 12 – 15
hours) or QD diffusion out of dividing cells over time
thus causing a dilution of QD signal. The dramatic
decrease in signal is consistent with a previous study that
used QDs to label human cervical adenocarcinoma cells
[10].
Another important question is whether QDs affect ES cell
properties (i.e., pluripotency and self-renewal) that make
them an attractive choice for regenerative therapy. Previ-
ous studies have shown that QD toxicity is dose depend-
ent with increasing concentrations affecting cell growth
and viability [24]. However, we were interested in any tox-
icity caused at concentrations used for labeling cells for in
vivo applications. Therefore, we examined ES cell prolifer-
ation and viability at one QD concentration (10 nM) and
observed no significant changes between QD labeled ES
cells and control unlabeled ES cells. This was true for all
QDs tested: QD 525, 565, 605, 655, 705, and 800. These
results concur with the study by Jaiswal et al. that also
showed no adverse effects by QDs on the viability, mor-
phology, function, and development of various other cells
[10]. Likewise, we confirmed that QDs also had no
adverse affect on ES cell differentiation based on RT-PCR
analysis of germ layer specific genes. Implanted ES cells
are known to form teratoma tumors with a variety of dif-
ferentiated tissues [25]. In Figure 6, we found that the ter-
atoma consisted of a variety of tissues including
respiratory epithelium, osteochondroid, squamous cell,
and immature brain-like neural cell based on histology.
This confirmed that QD labeling did not affect in vivo dif-
ferentiation as well. However, although ES cell-derived
teratomas were retrieved from the animals, they were not
shown to be QD labelled. We believe that the in vivo signal
could be due to uptake of QD by neighboring host cells.
Thus, the poor retention of QDs in targets cells may be a
problem for long-term tracking, and more detailed analy-
sis are needed to address this issue in the future.
Another advantage of QDs is their ability to do multiplex
imaging of different QDs at the same time. However, in
our study, ES cells labeled with different QDs were only
capable of being imaged up to day 2 after subcutaneous
implantation. A likely cause for this could be the loss of
signal due to rapid cell division. Another possible cause
could be serum instability of the QDs. Cai et al. reported
that QD 705 lost 14% of its original intensity after 24
hours of incubation in mouse serum [26]. Any loss of sig-
nal could hamper detection of QD labeled cells at laterBMC Biotechnology 2007, 7:67 http://www.biomedcentral.com/1472-6750/7/67
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Detection sensitivity of QD 800 imaging in live animals Figure 5
Detection sensitivity of QD 800 imaging in live animals. (A) 1 × 104, 1 × 105 and 1 × 106 QD 800 labeled ES cells were 
subcutaneously injected on the back of the mice right after labeling. The image was taken 1 hour post injection with excitation 
filter 465 nm and emission filter 510 nm long-pass, and the quantification of the fluorescent intensity (total signal-background/
exposure time (ms) was shown in (B). (C) After images were taken, the mice were imaged again with red excitation light 
source (640 nm) and the quantification of the fluorescent intensity was shown in (D). Longitudinal imaging of the same repre-
sentative animal for 1 month shows detection of QD signals up to day 14 (E).
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time points, especially those that are not within the near-
infrared region since signals from these QDs will also be
mostly absorbed by the skin. For those QDs that are in
near-infrared region, QD 705 and QD 800, the difference
in intensity could be due to transfection efficiency since
these two QDs have similar extinction coefficients and
quantum yield according to the manufacturer. However,
extinction coefficients and quantum yield data were
obtained in vitro and not in an animal setting. Moreover,
the transfection efficiency was similar across all QDs.
Therefore, we believe transfection efficiency is unlikely to
be the cause of the difference in intensity observed in vivo.
Due to its higher extinction coefficient and wider emis-
sion spectra within near-infrared region, only QD 800 sig-
nals were capable to be imaged in the animals for up to 14
days. We observed an increase in signal intensity when
using a red shifted excitation laser (640 nm) to image QD
800 labeled ES cells. The normal excitation wavelength is
465 nm. This was somewhat surprising since the excita-
tion coefficient of QD 800 is lower at 640 nm than it is at
465 nm. That is at 640 nm, QD 800 absorbs light with less
efficiency than at 465 nm, so less QDs become excited and
thus give off lower signal intensities. However, the tissue
penetration is much greater at 640 nm. Therefore, labeled
cells that would not have been excited at 465 nm could be
excited at 640 nm. Thus, these newly excited cells could
contribute to the greater signal intensity seen at the detec-
tion wavelength of 800 nm.
Conclusion
In summary, we report the successful demonstration of
labeling ES cells with QDs and imaging these labeled cells
in vivo. We have shown that it is feasible to label ES cells
with QDs by Q-Tracker with high efficiency. After labe-
ling, QDs did not affect the viability, and proliferation of
ES cells, and have no profound effect on differentiation
capacity of ES cells within the sensitivities of the screening
assays used. We tested multiplex imaging in vivo using the
Maestro system and showed that QD 525, QD 565,
QD605, QD 655, QD 705, and QD 800 labeled ES cells
can be detected in vivo using a single excitation wave-
length (465 nm). This versatility makes them good candi-
dates for tumor targeting [1], lymph node [3] and vascular
mapping [5], and cell trafficking [8,10] in small animal
imaging. Nevertheless, the use of QD in stem cells is only
beginning to be explored. To our knowledge, this is the
first demonstration of in vivo multiplex imaging of mouse
ES cells labeled QDs. Upon further improvements (e.g.,
near-infrared QDs, better serum stability, and improved
cell retention), QDs will have greater potential for track-
ing of stem cells within deep tissues.
Postmortem histological analysis of transplanted ES cells Figure 6
Postmortem histological analysis of transplanted ES cells. (A,D) respiratory epithelium with ciliated columnar and 
mucin producing goblet cells; (B,E) osteochondroid formation; (C) squamous cell differentiation with keratin pearl; and (F) 
immature brain-like neural cell formation.
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Methods
Culture of undifferentiated ES cells
The murine ES-D3 cell line (CRL-1934) was obtained
from the American Type Culture Collection (ATCC; Man-
assas, VA). ES cells were kept in an undifferentiated,
pluripotent state with 1000 IU/ml leukemia inhibitory
factor (LIF; Chemicon. ESGRO, ESG1107) and grown on
top of the murine embryonic fibroblasts feeder layer inac-
tivated by 10 ug/ml mitomycin C (Sigma). ES cells were
cultured on 0.1% gelatin-coated plastic dishes in ES
medium containing Dulbecco Modified Eagle Medium
supplemented with 15% fetal calf serum, 0.1 mmol/l β-
mercaptoethanol, 2 mmol/l glutamine, and 0.1 mmol/l
nonessential amino acids as described previously [27,28].
Flow cytometry and fluorescent microscopy
Trypsinized mouse ES cells were labeled with QD 655 (10
nM) using Qtracker according to the manufacturer's pro-
tocol. Briefly, 10 nM of labeling solution was prepared
according to the kit direction. Trypsinized mouse ES cells
(1 × 106) were added to the 0.2 ml of labeling solution.
After incubating at 37°C for 60 minutes with intermittent
mixing, the ES cells were washed twice with PBS to remove
any free QDs and plated on 0.01% gelatin coated plates.
Fluorescence microscopy (Carl Zeiss Axiovert 200M) was
used to image the cells on day 1. Labeled ES cells were
analyzed by flow cytometry (FACSCalibur; BD Bio-
sciences, San Jose, CA) using the FL3 channel to detect QD
655 labelled cells on days 1, 4, and 7 post-labeling. Acqui-
sition data were analyzed by the FlowJo software.
Effect of QDs on ES cell viability and proliferation
ES cells labeled with six different QDs (10 nM each) and
control unlabeled ES cells were plated uniformly in 96-
well plates at a density of 5,000 cells per well. Cells were
treated according to the manufacturer's protocol and read
out on a fluorescence microplate reader (SpectraMax
Gemini EM, Molecular Devices Corporation, Sunnyvale,
CA) at 24, 48, and 72 hours post labeling. For Trypan blue
exclusion assay (indicative of cell death), aliquots of
labeled cells were removed at specific time points and
mixed with Trypan blue. The number of dead cells was
determined by counting blue cells under a light micro-
scope.
Embryoid body formation and differentiation
ES cells were differentiated in vitro by the "hanging drop"
method as described previously [28-30]. Briefly, the main
steps included withdrawal of LIF and cultivation of 400
cells in 18 µl hanging drops to produce embryoid bodies
for 3 days, followed by cultivation as suspension in ultra-
low-cluster 96-well flat-bottom plates for 2 days. Next, the
embryoid bodies were seeded onto 48-well plates.
RT-PCR analysis of embryonic and germ layer specific 
transcripts
Reverse-transcription polymerase chain reaction (RT-
PCR) was used to compare the expression of embryonic
marker (Oct4), endoderm (alpha-1-fetoprotein, AFP),
mesoderm (fetal liver kinase-1, Flk1), and ectoderm (neu-
ral cell adhesion molecule, Ncam) germ layer markers
[21] between control unlabeled ES and QD-labeled ES
cells. Total RNA was prepared from cells with Trizol rea-
gent (Invitrogen) according to the manufacturer's proto-
col. The primer sets used in the amplification reaction
were as follow: Oct4 forward primer GGCGTTCTCTTT-
GCAAAGGTGTTC, reverse primer CTCGAACCACATCCT-
TCTCT; AFP forward primer TATCAGCCACTGCTGCAAC
T, reverse primer GTTCAGGCTTTTGCTTCACC; Flk1 for-
ward primer CACCTGGCACTCTCCACCTTC, reverse
primer GATTTCATCCCACTACCGAAAG; Ncam forward
primer GGAAGGGAACCAAGTGAACA, reverse primer AC
GGTGTGTCTGCTTGAACA. PCR products were separated
on 1% agarose gel electrophoresis and quantified with
Labworks 4.6 Image Acquisition and analysis software
(UVP Bio-Imaging Systems).
In vivo fluorescence imaging of QD-labeled ES cells
Right after labeling ES cells with QDs by QTracker, the
labeled cells were subcutaneously injected with Matrigel
(50 µl, vol. 1:1, BD Biosciences, San Jose, CA) into various
locations on the back of athymic nude mice (n = 6).
Images were taken with an excitation filter of 465 nm and
an emission filter of 510 nm long-pass using the Maestro
Optical imaging (CRI Inc, Woburn, MA) as shown in Fig-
ure 1b. Detection was set to capture images automatically
at 10 nm increments from 500 to 850 nm. The vendor's
software (Nuance 2p12_beta) determined the correct
exposure time for each QD labeled cells. The resulting
TIFF image was loaded into the software and analyzed.
Spectral unmixing was done using a user-defined library
according to manufacturer's direction for each QD.
Briefly, images of six different QD labeled ES cells in 1.5
ml micro-centrifuge tubes were taken separately. Each QD
library spectra was decided and set by unmixing autofluo-
rescence spectra and QD spectra manually selected from
the image using the computer mouse to select appropriate
regions. Images for QD800 sensitivity experiment was
taken with an excitation filter of 640 nm and an emission
filter of 700 nm long-pass.
Postmortem immunohistochemical stainings
After imaging, all animals were euthanized by protocol
approved by the Stanford Animal Research Committee.
Explanted subcutaneous teratomas were routinely proc-
essed for hematoxylin-and-eosin staining. Slides were
interpreted by an expert pathologist blinded to the study
(AJC).BMC Biotechnology 2007, 7:67 http://www.biomedcentral.com/1472-6750/7/67
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Statistical analysis
Data were presented as mean ± SD. For Statistical analysis,
the 2-tailed Student t test was used. Differences were con-
sidered significant at P < 0.05.
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